President Donald Trump is expected to nominate White House policy adviser and physician Dr. Heidi Overton to lead the US Food and Drug Administration (FDA), according to multiple outlets. Overton is currently a White House aide and would replace the FDA leadership that has been dealing with internal strain and staffing losses.
Several reports say Overton would take charge of an agency responsible for regulating food, drugs, medical devices, tobacco and related areas. NPR and Time note the FDA’s broad oversight role and large workforce size, while other outlets describe the agency as facing pressure to rebuild confidence among industry and public-health stakeholders. Free Malaysia Today highlights that the FDA has lost more than 3,000 staff, including division heads, over the past year.
Outlets differ on emphasis. CBS points to Dr. Scott Gottlieb’s view that Overton could be a strong candidate due to her deep policy background. The Hindu similarly describes her prospective role amid concerns that the regulator has become too political. Times of India focuses on aspects that draw scrutiny, including management experience and views tied to abortion medication. MedPage Today and NBC News primarily report the nomination and her professional background as a White House deputy director involved in domestic policy.
